About

Health Ministry To Integrate Mobile App For Reporting ADR With Global Regulators To Enhance Pharmacovigilance

Health Ministry To Integrate Mobile App For Reporting ADR With Global Regulators To Enhance Pharmacovigilance


Mumbai, 22 May 2018: Government is planning to integrate its mobile application by the name “ADR PvPI” meant for ADR reporting with global regulatory agencies to enhance pharmacovigilance (PV) for drug quality and patient safety. 

 

The mobile app has been developed to have administrative control of data with Indian Pharmacopoeia Commission (IPC) as the National Co-ordinating Centre (NCC) for PvPI. Through this application, related images of ADR and lab investigation reports can be attached in a user-friendly manner for clinical assessment and signal detection.

 

This mobile application will empower all the healthcare professionals and consumers for ADR reporting with features like supports source document and image attachment, healthcare professionals as well as consumer reporting, XML generation and auto filling of report details to save time.

 

The mobile application which has been developed keeping in mind the patients, consumers and healthcare professionals is now available online for stakeholders. 

 

PV is a science that relates to detection, assessment, understanding and prevention of adverse affects or any other drug related problem. To track adverse drug reactions in Indian population, union health ministry launched Pharmacovigilance Programme of India (PvPI)  in July 2010.

 

IPC is an autonomous institution of the ministry of health and family welfare created to set standards of drugs in the country. It’s basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region. It publishes official documents for improving quality of medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP). It further promotes rational use of generic medicines by publishing National Formulary of India.  

 

Following recent amendments in Drugs and Cosmetics Rules, 1945 and order from the Union health ministry to all states and Union Territories, the avenues in PV has widened and has become a priority area.

 

The professionals who have been trained on PV currently working in various healthcare institutions across the country have been motivated to take the onus of disseminating the knowledge and practices of PV for effective ADR monitoring. Pharmabiz